ISBCS
International Society of Bilateral Cataract Surgions
Congratulations to the Eye Foundation of Canada President, Steve A. Arshinoff MD FRCSC and the contributing globally acclaimed ophthalmic experts on the 2022 release of the comprehensive book: Immediately Sequential Bilateral Cataract Surgery Global History and Methodology.
Immediately Sequential Bilateral Cataract Surgery (ISBCS): Global History and Methodology is a comprehensive guide for the safe and efficient performance of ISBCS. It provides an overview of the history, recommended protocols, necessary precautions, exclusion criteria, benefits and risks associated with this procedure, organizational standards, and more.
Written by the most prominent ISBCS surgeons in the world, chapters recount the arguments for and against bilateral surgery that have been made throughout the ages, up to the present, and deliver achieved and proposed resolutions to all problems discussed. Topics such as ethics and medico-legal issues surrounding ISBCS are also discussed, and a chapter on the global evolution of bilateral cataract surgery provides readers with a complete overview of the development of ISBCS practices in countries from all continents.
- Provides a comprehensive history and current status of ISBCS globally
- Provides step-by-step recommendations and precautions necessary to perform ISBCS safely, including detailed discussion of surgical infection prophylaxis with antibiotics delivered into the eye at surgery
- Reviews and explains the patient benefits associated with ISBCS
- Covers development of ISBCS practices worldwide
The International Society of Bilateral Cataract Surgeons (iSBCS) ceased to operate January 1, 2020. In its 12 years of existence, the iSBCS has fulfilled its mandate. Immediately Sequential Bilateral Cataract Surgery is no longer rare and has been accepted, in most of the world, as being equally as effective as DSBCS (Delayed Sequential Bilateral Cataract Surgery) with many advantages. Rather than mourning its passing, this is a sign to rejoice that iSBCS has fulfilled its mission and the society is no longer needed. Further discussion of ISBCS will now move to the ASCRS, ESCRS, APACSRS and other multiple-issue societies, where it belongs.
Important archival documents of the iSBCS are hosted here, on the Eye Foundation of Canada website, where they will continue to be available. The executive would like to thank our members for their years of dedicated work and support.
Co-Presidents
Steve A. Arshinoff, Toronto, Canada
Bjorn Johansson, Linkoping, Sweden
Secretary-Treasurer
Charles Claoué, London, UK
Chair, Scientific Committee
Cyres Mehta, Mumbai, India
_
Founding members of iSBCS, Sept. 14, 2009, Barcelona
(Left to Right)
Javier Goas Iglesias De Ussel,
David Pérez Silguero,
Charles Claoué,
John Bolger,
Steve Arshinoff,
Ramón Foa Henriquez De La Fé,
Miguel Ángel Pérez Silguero,
Absent: Björn Johansson, Johann Kruger
Achievements of the International Society of Bilateral Cataract Surgeons
| 1. Annual Meetings of iSBCS at ESCRS | 2018 – 2020 |
| 2. ISBCS Terminology clarification | 2008 |
| 3. General Principles for Excellence in ISBCS | 2009 |
| 4. Clarification of advantages and risks of ISBCS | 2008 – 2020 |
| 5. Monitor Global ISBCS issues & complications | 2008 – 2020 |
| 6. Clarification of global monetary issues | 2008 – 2020 |
| 7. ISBCS successfully defended in debate at ASCRS by S. Arshinoff | 2014 |
| 8. ISBCS successfully defended in debate at ESCRS by S. Arshinoff | 2014 |
| 9. Formal Recognition of ISBCS as safe and effective by Government of Spain | 2010 |
| 10. Spanish Ophthalmology Society voted to include ISBCS into the protocols of the Spanish Ophthalmology Society as an effective alternative in cataract surgery. | 2020 |
| 11. Infection in ISBCS study | 2011 |
| 12. Mutual assistance and cooperation | 2008 – 2020 |
| 13. ISBCS Course presentations (ASCRS, ESCRS) | 2005 – 2018 |
Founding Executives:
President: Steve Arshinoff,
President Elect: Charles Claoué
Secretary-Treasurer: John Bolger
Help support the future of eye care
Your contribution helps support the future of ophthalmology through research and education.